Application

BREAKING THROUGH

Allergan Pharmaceuticals International Limited

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 98858307
Filing Date: 11/18/2024

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 98858307
MARK INFORMATION
*MARK BREAKING THROUGH
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BREAKING THROUGH
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Allergan Pharmaceuticals International Limited
*MAILING ADDRESS Clonshaugh Business & Technology Park
*CITY Dublin 17
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
D17E400
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE Private Company Limited by Shares
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 035 
*IDENTIFICATION providing medical information, namely, consumer product information regarding medical products to patients and healthcare professionals
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing medical information, namely, information regarding medical conditions, treatments and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Sonali S. Srivastava
ATTORNEY DOCKET NUMBER BREAKING THR
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME AbbVie Inc.
INTERNAL ADDRESS AP34-2/V377
STREET 1 N. Waukegan Road
CITY North Chicago
STATE Illinois
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 60064
FAX 847-938-2623
EMAIL ADDRESS sonali.srivastava@abbvie.com
OTHER APPOINTED ATTORNEY Cheryl A. Withycombe, Matthew O. Brady, Janie L. Thompson
CORRESPONDENCE INFORMATION
NAME Sonali S. Srivastava
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE sonali.srivastava@abbvie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kimberly.gleason@abbvie.com; trademarks@abbvie.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 700
*TOTAL FEES PAID 700
SIGNATURE INFORMATION
SIGNATURE /Sonali S. Srivastava/
SIGNATORY'S NAME Sonali S. Srivastava
SIGNATORY'S POSITION Attorney of Record/IL Bar Member
SIGNATORY'S PHONE NUMBER 847-937-4932
DATE SIGNED 11/18/2024
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 98858307
Filing Date: 11/18/2024

To the Commissioner for Trademarks:

MARK: BREAKING THROUGH (Standard Characters, see mark)
The literal element of the mark consists of BREAKING THROUGH. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Allergan Pharmaceuticals International Limited, a Private Company Limited by Shares legally organized under the laws of Ireland, having an address of
      Clonshaugh Business & Technology Park
      Dublin 17 D17E400
      Ireland
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 035:  providing medical information, namely, consumer product information regarding medical products to patients and healthcare professionals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing medical information, namely, information regarding medical conditions, treatments and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Sonali S. Srivastava. Other appointed attorneys are Cheryl A. Withycombe, Matthew O. Brady, Janie L. Thompson. Sonali S. Srivastava of AbbVie Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      AP34-2/V377
      1 N. Waukegan Road
      North Chicago, Illinois 60064
      United States
      847-938-2623(fax)
      sonali.srivastava@abbvie.com
The docket/reference number is BREAKING THR.
Sonali S. Srivastava submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Sonali S. Srivastava
       PRIMARY EMAIL FOR CORRESPONDENCE: sonali.srivastava@abbvie.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kimberly.gleason@abbvie.com; trademarks@abbvie.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Sonali S. Srivastava/   Date: 11/18/2024
Signatory's Name: Sonali S. Srivastava
Signatory's Position: Attorney of Record/IL Bar Member
Signatory's Phone Number: 847-937-4932
Signature method: Sent to third party for signature
Payment Sale Number: 98858307
Payment Accounting Date: 11/18/2024

Serial Number: 98858307
Internet Transmission Date: Mon Nov 18 10:57:01 ET 2024
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20241118105701
623808-98858307-870a1728754dc5d5c85334ac
06095fb2e55c5ae8a27bbde8987def5562839a89
b-DA-57017115-20241113152451104986

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2025 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed